[4-(Oxan-4-yloxy)phenyl]boronic acid, 97%, 500mg

Methyl 3-hydroxymethyl-1-methyl-1H-pyrazole-5-carboxylate, 95.0%, 1g

7-Benzyl-1,3,7-triazaspiro[4.4]nonane-2,4-dione, 95.0%, 1g

6-BROMO-4-CHLORO-2,3-DIHYDRO-1H-INDEN-1-ONE, 95.0%, 250mg

(R)-2-Amino-2-(m-tolyl)ethanol hydrochloride, 95.0%, 100mg

Récipient de réaction ROTILABO®, 20 ml, 1 pièce

Flacon à col étroit 301, 30 ml, 14 mm, 100 Pièce(s)

1-(3-Methoxyphenyl)cyclopropan-1-amine hydrochloride, 1g

Methyl 4-[6-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl]benzoate, 95.0%, 500mg

5-Chloro-1-pentyne>96.0%(GC)5mL

P-NITROBENZYL-6-(1-HYDROXYETHYL)-1-AZABICYCLO(3.2.0)HEPTANE-3,7-DIONE-2-CARBOXYLATE, 97.0%, 5g

tert-Butyl 2-bromo-6,7-dihydrothiazolo[4,5-c]pyridine-5(4H)-carboxylate, 95.0%, 250mg

2-(Dimethylamino)-3-phenylpropan-1-ol, 97%, 250mg